Eli Lilly to Acquire Calytrix Bio in Up to $1.5 Billion Deal
Where Will Eli Lilly Be in 10 Years? 1 Clue: Its Next Potential Blockbuster Just Beat Ozempic Head-to-Head
Lilly Bets Up to $1.5 Billion on Calytrix's Preclinical Antibody
Lilly to acquire Calytrix Bio in deal worth up to $1.5 billion
Eli Lilly to Acquire Calytrix Bio for Up to $1.5 Billion to Expand Blood Cancer Portfolio
Eli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should Know
Lilly adds to buyout streak with $1.5B purchase of startup Calytrix
What Does Eli Lilly (LLY) Reveal At ObesityWeek 2026 About Its Growth Path?
ETFs Are Net Sellers of Eli Lilly (LLY) on Nov. 12
Lilly To Acquire Closely Held Neoplasm Therapy Developer Calytrix Bio For Up To $1.5B In Cash
Reported Saturday, Lilly Presents Eloralintide Phase 2 Exit Interview Results, With 74% Reporting Fewer Cravings, 52% Less Food Noise, Alongside EloraTZP, Retatrutide, Zepbound And Foundayo Data At ObesityWeek 2026
Eli Lilly Stock: What Its 23% Weight-Loss Combo and 27% Dropout Rate Mean
Lilly to present new data across Zepbound, Foundayo, EloraTZP and retatrutide at ObesityWeek 2026, moving obesity care beyond the scale
Trump Touts Lilly’s “$3.5 Billion” Obesity Drug Plant, Its 10th New U.S. Site Since 2020
What Eli Lilly Doubters Overlooked
ETFs Are Buying Eli Lilly (LLY) on Nov. 11
Here’s How Much You Would Have Made Owning Eli Lilly Stock In The Last 5 Years
Lilly breaks ground in Pennsylvania's Lehigh Valley on a $3.5 billion site to make next-generation obesity medicines, the latest of 10 new U.S. sites since 2020
Jensen Huang Says AI's 'Most Profound Impact' Will Be in Life Sciences -- and Eli Lilly Is Already Building on It
Eli Lilly Breaks Ground On $3.5B Manufacturing Facility In Pennsylvania's Lehigh Valley; Site To Create 850 High-Wage Jobs And 2,000 Construction Jobs
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.